Veneno Technologies Inc.
Certified as an AISol startup.
Veneno Technologies Inc. has been certified as an AISol Startup.
[Image: https://prtimes.jp/i/91230/5/resize/d91230-5-0ad1e086eeabcee337d6-0.jpg&s3=91230-5-cf506bfee4d752473a1ce19b8ca9c480-353×113.jpg ]
June 5, 2023
Announcement of the first certification of AISol startup
Veneno Technologies Co., Ltd. (Headquarters: Tsukuba City, Ibaraki Prefecture, Representative Director: Toshinori Yoshikawa, hereinafter referred to as “the Company”) is AIST Solutions Co., Ltd.
(Headquarters: Tsukuba, Tokyo, Representative Director: Seiji Osaka). Received the first certification as a startup.
AIST Solutions was established on April 1 this year as a wholly owned subsidiary of the National Institute of Advanced Industrial Science and Technology (AIST), one of Japan’s largest public research institutes. We aim to strengthen open innovation, build an ecosystem, and create new businesses through aggressive marketing activities by utilizing our technological assets and research resources. Our technology for drug discovery of new pharmaceuticals, agricultural chemicals, biochemicals, etc. based on our disulfide-rich peptide (DRP) has been evaluated for its competitiveness and business concept, and has been certified as an AISol startup this time. .
[Comment from Toshinori Yoshikawa, Representative Director of Veneno Technologies Co., Ltd.]
“We are very honored to be certified as an AISol Startup.In the future, with the support of the AIST Group, we will further refine our technology and carry out research and development in order to realize the innovative drug discovery that we are aiming for as soon as possible. We will continue to push forward strongly.”
[Comment from Seiji Osaka, CEO of AIST Solutions Co., Ltd.]
“The company’s innovative technology that utilizes peptides, which is said to be a dream biopharmaceutical, has great potential and business value such as providing new therapeutic drugs, so we have certified it as an AISol startup and will fully support it. increase.”
About AIST Solutions Co., Ltd.
Company name: AIST Solutions Co., Ltd.
Location: (Tokyo) Hibiya Fort Tower, 1-1-1 Nishi-Shimbashi, Minato-ku, Tokyo (Tsukuba) 1-1-1 Umezono, Tsukuba City, Ibaraki Prefecture
Representative: Seiji Osaka
HP: https://www.aist-solutions.co.jp
About AISol Startup
AIST Solutions identifies start-up companies that are considered suitable for the management strategy of the AIST Group in terms of contribution to solving social issues, technological competitive advantage, marketability, and synergy with AIST. We will certify and promote business co-creation.
AIST Solutions will work together with AIST to support the growth of AISol startups from various aspects such as engineering, marketing, business acceleration, and capital increase, and promote
commercialization together.
■ Inquiries regarding this matter
Veneno Technologies Inc. (https://veneno.jp/)
Business Development Manager Hikaru Taira, Yasuhisa Matsukawa E-mail: info@veneno.jp
Disulfide-Rich Peptide (DRP) is a general term for peptides of about 20 to 60 amino acid residues with three or more disulfide bonds in the molecule. It has a tight molecular structure due to multiple intramolecular disulfide bonds, and is a molecule with high stability against heat, acid, and degrading enzymes compared to linear peptides. DRP exists widely in the natural world from bacteria to humans, but it is also found in animal venom, and is a functional peptide that has evolved as a major component of venom so that it has a strong effect even in a small amount. In recent years, it has attracted attention as a new drug discovery base molecule because it has excellent functions as a highly active and highly selective natural agonist.
Details about this release:
https://prtimes.jp/main/html/rd/p/000000005.000091230.html
Copyright (c) PR TIMES Corporation.